Moderate to severe hyperkalemia
ICD-10 E87.5 · ICD-11 5C76

Severe Hyperkalemia Not Responding to Glucose-Insulin or Salbutamol: Next-Line Management

Clinical Scenario

This protocol addresses severe or symptomatic hyperkalemia — serum potassium greater than 6.5 mmol/L, or a patient presenting with muscular weakness and/or ECG changes such as peaked T waves — where hourly potassium monitoring has not confirmed an adequate reduction with the initial management step.

When the Previous Step Was Not Enough

If initial treatment with glucose and insulin, inhaled salbutamol, or sodium bicarbonate (where indicated) has failed to achieve the treatment goal — a confirmed reduction in serum potassium level on hourly monitoring — this next-line protocol provides the structured approach for what to do next.

Next-Line Approach (Partial Overview)

At this stage, the clinical focus shifts to actively removing potassium from the body rather than redistributing it. Specific agents directed at elimination are involved, and in certain clinical situations an urgent intervention beyond pharmacological management may be required.

The complete structured regimen — including agent selection, sequencing, decision points, and monitoring — is available in the full protocol.

Treatment Goal

Reduction in serum potassium level, confirmed on hourly monitoring.

Instant Access to Structured Evidence-Based Regimens

References

View source ↗